Read Fennec Pharmaceuticals Inc. R (RV41.MU) Q2 FY2026 earnings call transcript on Yahoo Finance to keep your investing strategy up to date with all of the latest information ...
Fennec Pharmaceuticals delivered a seventh consecutive quarter of growth, with Q2 2026 net product sales rising 78% year-over-year to $17.1 million and non-GAAP adjusted EBITDA turning positive at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results